ArticleJournal of ultrasonography2025
Application of artificial intelligence in the ultrasonographic diagnosis of thyroid nodules.
Article in Journal of ultrasonography, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The aim of this study was to assess whether integrating selected ultrasound features into a convolutional neural network improves its ability to differentiate benign from malignant thyroid nodules. Material and methods: A total of 242 patients (196 women, 46 men) with thyroid lesions were included in the study. All patients underwent surgical treatment and histopathological analysis. Thyroid ultrasonography was also performed for all participants. Images were recorded in DICOM and AVI formats, and archived in a local database. Thyroid lesions were assessed according to the EU-TIRADS classification. Convolutional neural network models were developed using established architectures, including DenseNet and VGG16, as well as custom-designed models tailored to the dataset. Hybrid models were created by incorporating selected ultrasound features into these architectures as additional inputs. Performance was compared between the baseline convolutional neural network models and their feature-supported hybrid counterparts. Results: Model performance was evaluated using several metrics, including sensitivity and area under the ROC curve. Baseline convolutional neural network models served as the reference, while hybrid variants included structured ultrasound features. The VGG model showed a sensitivity of 0.78, and DenseNet achieved a sensitivity of 0.80 with an AUC of 0.84, demonstrating low variability. Inception models performed similarly, with balanced positive predictive value (PPV) (0.83) and negative predictive value (NPV) (0.74). Custom models also reached AUC values over 0.80. Selected ultrasonography features improved AUC by up to 7%, with additional gains in sensitivity and NPV. Conclusions: Eight baseline convolutional neural network models used to differentiate benign from malignant thyroid nodules were enhanced by incorporating five expert-assessed ultrasound features. This hybrid approach improved classification performance across all models, yielding an average AUC increase of approximately 7%.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.